Loading organizations...
Artemis Growth Partners is an investment firm specializing in ESG and impact investing within the global cannabis industry. The firm allocates capital across the cannabis value chain, including branded products, distribution, and research platforms. They integrate rigorous governance and strategic controls into each investment, fostering sustainable growth and positive societal impact.
Co-founded in 2015 by William Muecke and E. Stanton McLean, Artemis Growth Partners originated from the insight to apply robust ESG and impact investment frameworks to the nascent global cannabis sector. Muecke, a former senior banker at Goldman Sachs & Co., and McLean, previously a managing director at JPMorgan, brought significant financial expertise.
The firm serves cannabis entrepreneurs and institutional investors focused on responsibly managed assets. Artemis Growth Partners' vision is to drive value creation, improving outcomes for owners, employees, communities, and patients through ethical governance, regenerative practices, and fostering a more inclusive world.
Artemis Growth Partners has 2 tracked investments across 2 companies. The latest tracked deal is $31.0M Series B in Nabis in June 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jun 1, 2021 | Nabis | $31.0M Series B | — | Anthemis Group, Crosslink Capital, Pelion Venture Partners, TMV, U.S. Department OF Defense, Jett Mccandless, Stanton Green, TED Serbinski, Stanley Tang, FJ Labs, Liquid 2 Ventures, Silverleaf Venture Partners |
| Jan 23, 2020 | NOBL Group | $1.6M Series A | — | Michael Goldberg, Enexis |
